Dulaglutide, a glucagon‐like peptide‐1 (GLP‐1) analog, is a once‐weekly GLP-1 receptor agonist (GLP‐1RA) used for the treatment of T2DM. Here, GLP1R is linked to type 2 diabetes mellitus.